Abstract Sudden death of healthy young adults in the absence of any medical reason is generally categorised as autopsy-negative sudden unexplained death (SUD). Approximately 30 % of all SUD cases can be explained by lethal sequence variants in cardiac genes causing disturbed ion channel functions (channelopathies) or minimal structural heart abnormalities (cardiomyopathies). The aim of this study was to perform whole-exome sequencing (WES) in five young SUD cases in order to identify potentially disease-causing mutations with a focus on 184 genes associated with cardiac diseases or sudden death. WES analysis enabled the identification of damaging-predicted cardiac sequence alterations in three out of five SUD cases. Two SUD victims carried disease-causing variants in long QT syndrome (LQTS)-associated genes (KCNH2, SCN5A). In a third case, WES identified variants in two genes involved in mitral valve prolapse and thoracic aortic aneurism (DCHS1, TGFβ2). The genome of a fourth case carried several minor variants involved in arrhythmia pointing to a multigene influence that might have contributed to sudden death. Our results confirm that postmortem genetic testing in SUD cases in addition to the conventional autopsy can help to identify familial cardiac diseases and can contribute to the identification of genetic risk factors for sudden death.
Introduction
Sudden death (SD) of a previously healthy adolescent or young adult is a tragic and distressing event for those left behind. Depending on the underlying cause of death, SD can be divided into sudden cardiac death (SCD) or sudden death due to non-cardiac causes such as pulmonary embolism, metabolic, neurological, or infectious conditions [1, 2] . In elderly persons, SCD is mainly caused by coronary artery disease (CAD), whereas in young people (between 1 and 39 years of age), a complete post-mortem examination fails to reveal a cause of death in up to 30 % of all cases [3, 4] . These are generally designated as autopsy-negative sudden unexplained death (SUD) cases. Although SCD is one of the major causes of mortality worldwide, the exact incidence of SUD in young individuals remains unknown in most countries [5, 6] .
It is estimated that up to 30 % of all SUD cases carry sequence variants in known cardiac genes causing lethal cardiac arrhythmia in a morphological normal heart [3, 7, 8] . Channelopathies primarily affect the heart rhythm and cardiac electrical conduction including cardiac diseases such as long QT syndrome (LQTS), short QT syndrome (SQTS), Electronic supplementary material The online version of this article (doi:10.1007/s00414-016-1317-4) contains supplementary material, which is available to authorized users.
catecholaminergic polymorphic ventricular tachycardia (CPVT), Brugada syndrome (BrS), and idiopathic ventricular fibrillation (IVF) [9] . Cardiomyopathies on the other hand refer to myocardial disorders characterised by a structural and functional abnormal heart muscle [10] . The most common form is hypertrophic cardiomyopathy (HCM) followed by other cardiomyopathies such as arrhythmogenic right ventricular cardiomyopathy (ARVC), idiopathic dilated cardiomyopathy (DCM), and left ventricular non-compaction cardiomyopathy (LVNC) [11] .
Post-mortem genetic testing by using specific gene panels or whole-exome sequencing (WES) represents an efficient tool to elucidate potential disease-causing mechanisms, which remained undetected during autopsy [8, 12, 13] . The exome represents approximately 1-2 % of the human genome, but it accounts for over 85 % of all mutations that have been identified in Mendelian disorders [14] . Loporcaro et al. recently published a first proof-of-principle case report of a WESbased comprehensive molecular autopsy of an otherwise healthy 16-year-old SUDY (SUD in the young) victim, where they identified a pathogenic MYH7 mutation, previously described in familial HCM, sudden death, and impaired MHC-β actin-translocating and actin-activated ATPase activity [12] . Further studies described the detection of eight ultra-rare variants in seven of 14 Caucasian SUDY victims by focusing on 117 sudden death-susceptibility genes and the identification of likely pathogenic variants in 34 genes in 20 % of forensic SUD cases [8, 15] . Post-mortem genetic analysis of SUD victims may not only enable an accurate determination of cause and manner of death, but may also have significant impact for affected living first-degree family members in whom deathpredisposing disorders had remained unrecognised so far [16, 17] .
At the Zurich Institute of Forensic Medicine (ZIFM), University of Zurich, Switzerland, approximately 10 sudden death cases in young individuals are reported annually to show no or only minor morphological abnormalities during autopsy, leaving those left behind without any explanation about the exact cause of death. WES is not substantially more expensive than a targeted approach using a gene panel, but allows additional examination of new candidate genes in case of a negative result within the predefined gene list. In this study, we performed WES analyses in five unrelated SUD cases by focusing on 184 cardiac disease-associated genes. We wanted to test whether such a procedure could be implemented as a standard operating procedure to investigate or uncover lethal cardiac diseases.
Material and methods
Five unrelated sudden unexplained death cases (four females and one male) were collected between March and May 2012 at the ZIFM, Switzerland. All SUD cases were examined according to standard forensic procedures, including death scene investigation, a complete autopsy examination with pharmacological-toxicological and histopathological screening, and review of the clinical history. Inclusion criteria were (1) younger than 40 years of age, (2) only minor abnormalities in the heart, and (3) suspicion of an inherited cardiac disease or underlying cardiac arrhythmia contributing to sudden death. DNA of firstdegree relatives of the five SUD cases was not available for co-segregation analysis.
Ethical approval
Ethical approval for this study was provided by the local committee in Zurich (KEK-ZH-Nr. 2013-0086), and the study was conducted in full conformance with Swiss laws and regulations.
DNA sample collection and extraction
Five-milliliter EDTA blood samples from the five SUD cases were collected during autopsy and were stored at −20°C. Genomic DNA was extracted using the Gentra Puregene Blood Kit (Qiagen, Hombrechtikon, Switzerland) according to the manufacturer's protocol and quantified using the NanoDrop2000 (Fischer Scientific, Wohlen, Switzerland).
Exome sequencing
Exome capture, sequencing as well as sequence alignment and variant calling were performed at Atlas Biolabs (Berlin, Germany). Nimblegen SeqCap EZ Human Exome Library v.2.0 (Roche NimbleGen Inc., Madison, USA) was used for library preparation, and sequencing was done on the Illumina HiSeq2000 platform (Illumina Inc., San Diego, USA) generating 2 × 100 bp paired-end reads [18] . Alignment of sequence reads, indexing of the reference genome (hg19), and variant calling and annotation was done with a pipeline based on BWA [19] , Samtools [20] , and Picard and Annovar [21] .
Filtering steps and data analysis
Variant filtering included a gene panel of 184 genes associated with cardiac diseases or cardiac death (Supp. Table  S1 ). Annotation of these genes was conducted with the software Alamut HT version 1.1.7 (Interactive Biosoftware, Rouen, France). Output results were imported into an excel-sheet for further analysis. At first, variants were checked manually if they are disease-associated according to entries from the Human Gene Mutation Database Professional (HGMD®) (BIOBASE GmbH, Wolfenbüttel, Germany) (Fig. 1) . To include known modulator and risk factor variants into data analysis, HGMD®-reported variants were not filtered for a threshold minor allele frequency (MAF). The filtering steps for all other variants focused on (1) a global MAF value less than or equal to 0.02 (based on dbSNP); (2) exonic and splice site (+1, +5) variants; (3) exonic InDels, missense, and nonsense variants; and (4) deleterious or damaging protein predicted functions according to the following in silico predictive algorithms: MAPP (multivariate analysis of protein polymorphism prediction), SIFT (sorting intolerant from tolerant prediction), PolyPhen2, AGVGD (align Grantham-variation Grantham-deviation), and MutationTaster. Sequence alterations at the 5′ donor splice sites +1 and +5 were included into data analysis, because variants at these positions are thought to significantly reduce the pairing of the donor splice site with the complementary site in the small nuclear ribonucleoprotein particle U1snRNP, which is one of the first steps in the complex process of messenger RNA (mRNA) splicing [22] . Alamut Visual version 2.4.7 (Interactive Biosoftware, Rouen, France) was used to visualise the coverage of variants and to review conservation of the variants across a variety of species (based on Ensembl Genome Browser, http://ensembl.org). European allelic frequencies were examined in dbSNP at NCBI (www.ncbi. nlm.nih.gov/projects/SNP/), Ensembl, and in the exome aggregation consortium database (ExAC) (http://exac. broadinstitute.org/).
Possible disease-causing variants must be absent or rare in public databases (dbSNP, ExAC) or in 288 analysed controls (177 males, 111 females) from the general Swiss population.
As a final step, genes identified with disease-causing variants were analysed for splice site and/or synonymous variants.
Confirmation and validation of variants
Potential disease-causing variants found in whole-exome sequencing data of the five SUD cases were confirmed and screened in 288 controls by using standard polymerase chain reaction (PCR) and Sanger sequencing methods (primer sequences available on request). Sequence data were aligned to the reference sequence with the SeqScape® software version v2.6 (Life Technologies, Rotkreuz, Switzerland) (Supplementary data).
Results
Whole-exome sequencing was performed in five unrelated SUD cases. Data were analysed with respect to sequence variants with a focus on 184 genes previously associated with cardiac diseases or cardiac death. WES yielded an average of 87 433 402.8 total reads, and 87.44 % of the target positions were covered at least 30 times (Table 1) . Within the exome sequencing data, the five cases had on average 40 658 ± 613.2 single nucleotide variants (SNV) and insertion/deletions (InDels) causing amino acid changes (missense variants) on average in 10 788.4 ± 162.2 variants. By focusing only on the cardiac gene panel, on average 633.2 ± 10.6 variants were obtained per case. After all filtering steps, 23.4 ± 6.3 variants were used for further manual evaluation. 
Case I
Case I was a 27-year-old woman (weight, 54.1 kg; height, 172 cm; European origin) found dead on a sofa by her roommate late in the evening. Autopsy investigations showed a normal heart size (330 g) according to Zeek [23] , but a swollen and oedematous mitral valve with connective tissue changes in papillary muscles and thickening of tendinous chords (Supp. Fig. S1a ). Histological examination of the mitral valve revealed thickening and mucoid swelling of the tissue with signs of collagenous destruction (Supp. Fig. S1b ). Microbiological, virological, and pharmacological-toxicological screening results were all negative and showed no signs of an acute inflammation prior to death. At least two potential disease-causing heterozygous variants were detected in the 27-year-old woman (Table 2) . A missense variant was located in the dachsous cadherinrelated 1 gene (DCHS1; NM_003737.2: c.3415C > T: p.Arg1139Cys) with disease-causing protein function predictions and an allele frequency of 3.7e-05 in the general population (ExAC). The second variant was a one nucleotide, frame-shifting deletion in the transforming growth factor beta 2 gene (TGFβ2; NM_001135599.2: c.440delC: p.Pro.147 Argfs*27) leading to a truncated protein, not previously described in respective databases or in the scientific literature.
The ancestral alleles of both variants were highly conserved during evolution.
Case II
Case II was a 30-year-old woman (weight, 51.6 kg; height, 166 cm; European origin). She collapsed in the bathroom and was brought into her bed, where she died shortly afterwards. She had severe depression and was alcohol-dependent. Chemical screening tests detected a massively increased amount of butyric acid (almost a lethal concentration of 2500 μmol/L) and further pathological metabolic products such as acetone. Pharmacologicaltoxicological screening tests detected therapeutic concentrations of benzodiazepines in the peripheral blood. Autopsy investigations showed a heart weight of 390 g (24 % enlarged according to Zeek) with an adipose right ventricle and focally enlarged myocytes.
Within the 184 cardiac genes, we found at least two important possibly phenotype-relevant heterozygous missense variants (Table 2) . One variant (rs76906304) was located in the gap junction protein delta 4 gene (GJD4; NM_153368.2: c.259C > T: p.Leu87Phe). The second variant was detected in the junctophilin type 2 gene (JPH2; NM_020433.4: c.1013A > G: p.Glu338Gly), not previously described in the literature or public databases. Both variants were predicted to be disease-causing/damaging according to the in silico predictive algorithms.
Case III
Case III was a 31-year-old man (weight, 87.6 kg; height, 186 cm; European origin) who was found dead sitting on the toilet in his apartment. He worked in a restaurant kitchen, but did not appear to his working shift although he was seen shortly before and was considered to be reliable. On the evening before, he has attended a concert with some colleagues where they allegedly consumed different drugs. The autopsy showed a moderate enlarged heart (390 g) without further morphological abnormalities. Post-mortem pharmacological-toxicological screening results were positive for cannabis and amphetamine.
Further investigations of the medical history revealed a long QT syndrome (LQTS) diagnosis which was already detected in his adolescence based on electrocardiography (ECG) results (Supp. Fig. S2 ). His physician recommended an annual medical check including an ECG stress test, but he did not prescribe any medications. Two of the deceased's brothers and mother had the same diagnosis of LQTS, but without any implications so far (Supp. Fig. S3 ). Within the cardiac gene panel, we found two nonsense alterations and two missense variants (Table 2) . One stop variant (rs121912509) was detected in the gene encoding the potassium voltage-gated channel, subfamily H, member 2 (KCHN2; NM_000238.3: c.3002G > A: p.Trp1001*), reported as a LQT2 disease-causing mutation according to HGMD®. Due to the low number of reads (coverage = 6) at this position, Sanger sequencing was performed to confirm the variant (supplementary data). A second stop variant (rs140704891) was identified in the RAN guanine nucleotide release factor gene (RANGRF; NM_016492.4: c.181G > T: p.glu61*) and is classified as an in vitro or in vivo functional polymorphism in HGMD®. Two potentially disease-relevant heterozygous missense variants were located in the desmoplakin g ene (DSP ; N M_00 4415. 2: rs78652 302: c.5498A > T: p.Glu1833Val) and in the myosin heavy chain 7 gene (MYH7; NM_000257.2: rs3729823: c.4472C > G: p.Ser1491Cys). Both variants were described as possible disease-causing mutations according to HGMD® (rs78652302: dilated cardiomyopathy and rs3729823: hypertrophic cardiomyopathy), and protein effects were predicted to be deleterious (SIFT), probably damaging (polyphen2), and disease-causing (MutationTaster). MAF for both variants is 1 % in the general population, but shows a variable frequency within the European population (Ensembl: rs78652302: 1-3%T and rs3729823: 0-3 %G).
Case IV
Case IV was a 38-year-old woman (weight, 58.8 kg; height, 162 cm; Tibetan origin). She was found dead in the morning by her 10-year-old daughter who was sleeping in the same bed. Since several weeks, the woman complained about the air conditioner at her new job as she had a cold, but was otherwise healthy. Autopsy findings showed a normal heart size (250 g) and a slightly fatty infiltrated right ventricle without any further morphological abnormalities. Family history was negative for cardiac diseases or sudden death.
Genetic testing identified no rare disease-causing sequence variants within the cardiac gene panel, but the woman had several minor variants which probably affect function ( Table  2) . One heterozygous missense variant was located in KCNH2 (rs1805123: c.2690 T > G: p.Lys897Thr) and is associated with atrial fibrillation and drug-induced arrhythmia according to HGMD®. Although the minor allele is common in the European population (20%G), the variant is significantly less common in the Asian population (4%G). Further heterozygous missense variants were located in DSP (rs28763971: c.8605A > G: p.Ille2869Val), in the potassium voltage-gated channel, KQT-type gene (KCNQ1; NM_000218.2: rs12720449: c.1343C > G: p.Pro448Arg), and in the sodium channel type 10 gene (SCN10A; NM_006514.2: rs148041371: c.3291C > G: p.Ille1097Met). Although all three sequence variants are very rare in the European population, they are much more common in the Asian population (Ensembl: rs28763971: 2%G; rs12720449: 11%G; rs148041371: 2%G).
Case V
Case V was a 19-year-old woman (weight, 68.4 kg; height, 170 cm; European origin) who gave birth to her first child 2 months before she died. She had a minor cough, but was otherwise healthy when she suddenly collapsed at her home. The ambulance transferred her to the hospital where lifesustaining measures were stopped after the diagnosis of myocardial infarction and irreversible brain damage. Autopsy investigation showed a broadening and fatty infiltrated right ventricle possibly indicating ARVC (Supp. Fig. S4 a, b) , and the heart was slightly enlarged (300 g). Pharmacologicaltoxicological screening tests were negative for drugs and alcohol. Further investigations of the family history showed that a niece of the deceased died suddenly at the age of 11 during sports, and the grandfather died suddenly while sweeping snow at the of age of 77 (Supp. Fig.S5 ). Furthermore, her mother had minimal prolongation of the heart rate corrected QT intervals (QTc) of 460-480 ms [24] ; however, she did not follow further medical examinations. The toddler of this young woman has been under medical observation, a QTc prolongation (495 ms) has been detected during sleep, but the echocardiogram was normal.
Analysis of sequence variants within the 184 cardiac genes revealed two heterozygous variants in the voltage-gated sodium channel type V, alpha subunit (SCN5A) ( Table 2) . One missense variant was located in exon 28 (NM_001099404.1: c.5320A > C, p.Asn1774His) and was not previously reported in the literature and in public databases. A second missense variant was located in exon 12 (NM_001099404.1: rs1805124, c.1673A > G, p.His558Arg) and is described as disease-associated polymorphism with additional supporting functional evidence according to HGMD®. However, prediction algorithms described the variant as tolerated, and MAF is 21 % in the general population.
Discussion
Molecular testing in autopsy-negative death cases can identify the underlying mechanisms for sudden death and may represent an efficient tool in combination with standard forensic investigations to identify or confirm the suspicion of an inherited sudden death-predisposing disorder [8] .
In this study, genetic testing by using WES enabled the identification of potential lethal cardiac disease-associated alterations in three out of five SUD victims (Table 3) . A fourth case carried several minor variants pointing to a multigene influence instead of a strong autosomal-dominant sequence variant which could explain the phenotype.
C a s e I h a d o n e m i s s e n s e v a r i a n t i n D C H S 1 (p.Arg1139Cys) and a one nucleotide frame-shift deletion in TGFβ2 (p.Pro.147 fs*27). Sequence variants in both genes were already reported in mitral valve prolapse (MVP), which is a valvular heart disease characterised by the displacement of an abnormally thickened mitral valve leaflet into the left atrium during systole leading to serious complications, including arrhythmia, heart failure, and sudden death [25] . Reanalysis of the case report showed that the young woman had scoliosis and was very tall with long, slender limbs and fingers. Point mutations and whole-gene deletions/duplications in TGFβ2 are reported in patients with Loeys-Dietz syndrome (LDS), familial thoracic aortic aneurysms, and acute aortic dissection (TAAD) associated with mild systemic features of Marfan syndrome (MFS) [26] . Phenotypical features and genetic testing strongly indicated that the young woman had an underlying connective tissue disease, obviously not diagnosed during her lifetime, which might have contributed to mitral valve prolapse leading to the sudden death of this young woman.
WES analysis in case II identified two variants in GJD4 (p.Leu87Phe) and JPH2 (p.Glu338Gly). Connexins, such as GJD4, are transmembrane proteins involved in the formation of gap junction channels in the heart. Alterations in the connexin family are associated with cardiac arrhythmias and sudden infant death syndrome (SIDS) [27, 28] . Junctophilin type 2 is a cardiac member of the junctional membrane complex proteins, and JPH2 knockout mice demonstrated embryonic lethality and irregular calcium handling suggesting a crucial role for junctophilin-2 in facilitating intracellular calcium release and cardiac contractility [29] . Sequence variants in JPH2 were reported in atrial fibrillation due to impaired ryanodine receptor Ca 2+ channels (RyR2) stabilisation and in familial HCM [30] . Although the primary cause of death in this young woman was already diagnosed due to metabolic imbalance, the two GJD4 and JPH2 variants could have contributed to the morphological abnormalities in her heart, triggering the sudden death event during a critical time period.
Case III carried two nonsense sequence variants in RANGRF (p.glu61*) and KCNH2 (p.Trp1001*). RANGRF protein regulates the expression and function of SCN5A (Nav1.5) cardiac sodium channel. Electrophysiological studies in CHO-K1 cells demonstrated that the p.Glu61* stop completely failed to increase the sodium channel current compared to wild-type and may increase the risk of arrhythmias [31] . The Nav1.5 interacting part of RANGRF is positioned in the amino acid range 65-186 and hence a truncated protein produced from the affected allele would presumably not bind to the Nav1.5 leading to a loss of function [32] . KCNH2 encodes the pore forming subunit of the rapidly activating delayed rectifier K + channel (I Kr ) in the heart. Sequence variants are associated with delayed cardiac repolarization and prolonged QTc intervals leading to ventricular arrhythmias and sudden death [33] . The stop variant (c.3002C > T; p.Trp1001*) affects the C-terminus region of the KCNH2 protein leading to assembly abnormality caused by a reduction of mutant mRNA transcripts by nonsense-mediated mRNA decay [34] . The p.Trp1001* could be the major underlying pathogenic sequence alteration causing QTc interval prolongation in this young man, confirming the ECG-based clinical diagnosis of LQTS. In addition, QTc interval prolongation is described in patients taking amphetamine-type stimulants [35] , also detected in therapeutic concentration in this 31-year-old man.
Genetic testing in case IV identified one variant in KCNH2 (p.Lys897Thr) and several borderline variants in arrhythmiaassociated genes (DSP: p.Ille2869Val; KCNQ1: p.Pro448Arg; SCN10A: p.Ille1097Met). Although sequence variants in KCNH2 are described in drug-induced QTc prolongation [36] , we have no evidence if the woman had taken any medications against her cold prior to death. The common p.Lys897Thr is associated with an increased risk of developing torsade de pointes in the subacute phase of myocardial infarction and is described as a genetic modifier of latent congenital LQTS [37, 38] . Furthermore, cases with multiple borderline variants are more susceptible to develop diseases, even in the absence of strong dominant mutations that explain the phenotype. One major problem during data analysis was that the allelic frequencies of Tibetan origin were not available in public databases, complicating accurate interpretation of the found sequence variants. Case V carried a missense variant in SCN5A (p. Asn1774His) not previously reported in public databases. Kato et al. described a 1-day-old boy with prolonged QTc intervals (680 ms) having asparagine to aspartic acid replacement at the same position (rs199473633, c.5320 T > C, p.Asn1774Asp), and his brother died suddenly in infancy [39] . A functional assay demonstrated that p.Asn1774Asp channels carried significantly larger late components of sodium current than wild-type cells. The same amino acid replacement (p.Asn1774Asp) was also reported in a male foetus, which showed typical clinical signs of LQT3 (convulsion, ventricular tachycardia, torsade de pointes, atrioventricular block, and QTc intervals of 670 ms) [40] . To investigate the consequences of the asparagine to histidine amino acid change found in this young woman, functional studies are required in order to study the biological relevance of this substitution. The second missense variant in SCN5A (p.His558Arg) is described as phenotype modifier in LQTS and might amplify or modulate the functional electrophysiological impairment of genetic variants located in the same gene [41, 42] . Genetic analysis could not confirm a suspected ARVC although histopathological findings indicated clear fibro-fatty tissue infiltration with replacement of the myocardium in the right ventricle. Approximately 50 % of ARVC cases remain negative after genetic testing. This might be explained by the complex genetic background of ARVC and low penetrance making it difficult to identify the true disease-causing variants accurately [43] . In summary, morphological abnormalities in the heart led to an ARVC suspicion during autopsy; however, genetic testing could not confirm this suspicion but indicated a possible disturbed ion channel function. In the end, both of them could have contributed to cardiac arrhythmias triggering her lethal cardiac infarction.
WES is one of the most commonly used new sequencing approaches and major advantages are a high throughput, well established sample preparation methods, and relatively low preparation and sequencing costs compared to traditional Sanger sequencing [44] . Additionally, sample preparation and sequencing can be performed from a small input amount of DNA, which can be crucial for post-mortem samples where the amount of available tissue and the DNA quality are limited. Library preparation and sequencing costs are comparable to a targeted gene approach, but the WES data analysis can be extended to the whole exome in order to identify new candidate genes in cases where the analysis remained negative within a predefined gene panel.
Significant challenges in WES represent the handling and processing steps of such huge amount of sequencing data, which requires a variety of computational and statistical approaches [45] . Consequently, sequencing data analysis and mainly interpretation are time-consuming and require expertise in the field to prevent false-positive or false-negative results. Although filtering strategies and protein prediction tools can help to interpret the pathogenicity of variants, pathological and functional consequences of variants often remain unclear and require further functional studies [46] . Negative genetic testing otherwise may be secondary to disease-causing sequence variants within genes not included in the cardiac gene panel, due to sequence alterations not detectable in WES approaches, such as deep intronic or splice mutations, or due to variants lost during bioinformatics steps rather than due to real absence of any sequence alterations. Accurate interpretation is even more difficult in complex multifactorial phenotypes such as in sudden unexplained death cases without any obvious morphological abnormalities, and lethality may be triggered by different events such as stress, drugs, or physical exertion [47] .
The legal and ethical aspects of genetic analysis in forensic post-mortem investigations are complex, as the main forensic purpose is to determine the cause of death and not its implications for surviving relatives [48] . Therefore, genetic counselling of family members should be based on a multidisciplinary approach involving forensic pathologists, geneticists, and cardiologists to provide the family an opportunity to be informed in case of positive findings and offering them further clinical evaluation. Nowadays, minor preventive measures such as lifestyle modifications, prophylaxis, drug therapy, and implantable defibrillators are available in most cardiac diseases preventing another tragedy within the family [2] . In this study, genetic counselling of first-degree relatives was performed in two of the cases with potential diseasecausing variants (case III and case V), whereas the relatives of the other three cases were not available for counselling. Furthermore, functional studies to confirm the pathogenicity of found variants and family cosegregation analysis would have been crucial to verify the possible disease-causing impact of the observed variants, which are potential limitations of this study. DNA from family members of the five SUD cases was not available for co-segregation analysis, and hence, it is unknown if the observed variants were inherited from the parents or occurred de novo in the deceased.
In general, post-mortem genetic testing demonstrates an efficient strategy to investigate the cause of death in autopsy-negative sudden death cases. However, one of the major challenges remains the data management and variant interpretation of the huge amount of exome sequencing data and results should be regarded with caution.
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